全国第六届介入心脏病学论坛纪要

由中华医学会主办、中华医学杂志英文版、中国介入心脏病学杂志、南京医科大学第一附属医院、中华医学会心血管病介入治疗培训中心、中华医学会组织部和中华医学会继续教育部承办的“全国第六届介入心脏病学论坛”于 2 0 0 3年4月 9日至 14日在南京举行。本次大会有正式代表约 15 0 0余人 ,特邀代表 30 0余人 ,旁听代表以及厂商代表 30 0余人 ,共约 2 10 0余人 ,是一次规模庞大、隆重热烈、学术气氛浓厚的大会。中华医学会领导、国内德高望重的老一辈专家和本专业著名学者出席了会议。大会收到学术论文 110 0篇 ,专题发言 87个 ,优秀论文交…     

全国第六届介入心脏病学论坛征稿启事

由中华医学会中华医学杂志英文版、中国介入心脏病学杂志、中华医学会组织部、中华医学会继续教育部主办 ,中华医学会心血管介入治疗培训中心协办 ,南京医科大学和东南大学医学院承办的第六届全国介入心脏病学论坛 ,将于 2 0 0 3年 3月下旬在南京市举行。现开始征文 ,征文具体内容如下 :(1)冠心病诊断及介入治疗经验与展望 ;(2 )心律失常诊断及介入治疗经验与展望 ;(3)瓣膜病变与经皮瓣膜球囊成形术及展望 ;(4)先心病诊断及介入治疗经验与展望 ;(5 )外周血管病变的介入治疗与展望 ;(6 )各种介入治疗典型病例疑难病例讨论 ;(7)各种介入治疗新…     

第十四届全国介入心脏病学论坛

由中国医师协会、中国医师协会心血管内科医师分会、中华医学会心血管病分会主办，中国介入心脏病学杂志承办的第十四届全国介入心脏病学论坛将于2011年3月24日-27日在山东济南举办。     

第15届全国介入心脏病学论坛通知

由中国医师协会、中国医师协会心血管内科医师分会、中华医学会心血管病学分会、中国医学基金会主办,中国介入心脏病学杂志、北京力生心血管健康基金会、北京麦迪卫康广告有限公司承办,广西医科大学附属第一医院协办的第15届全国介入心脏病学论坛将于2012年3月1-4日在广西南宁举行。     

第15届全国介入心脏病学论坛通知

由中国医师协会、中国医师协会心血管内科医师分会、中华医学会心血管病学分会、中国医学基金会主办,中国介入心脏病学杂志、北京力生心血管健康基金会、北京麦迪卫康广告有限公司承办,广西医科大学附属第一医院协办的第15届全国介入心脏病学论坛将于2013年3月1～4日在广西南宁举行。     

第十四届全国介入心脏病学论坛会议纪要

2011年3月24至27日,第十四届全国介入心脏病学论坛在山东省济南市山东大厦隆重举行,来自全国各地以及部分海外华人学者共5000余人参加了本界学术盛会。论坛在医师协会、医学会领导们的大力支持下,     

第十九届全国介入心脏病学论坛会议纪要

<正>2016年4月22日至24日,河北省石家庄市春光正好,来自全国的4000多名心血管医护人员在这里迎来了第十九届全国介入心脏病学论坛。本届论坛由中国医师协会、中国心血管健康联盟、中国介入心脏病学杂志主办,河北医科大学第二医院、河北省医     

第十三届全国介入心脏病学论坛会议纪要

3月的郑州,乍暖还寒.第十三届全国介入心脏病学在现代化的郑州国际会展中心胜利闭幕了.作为国内历史最为悠久的高水平的心脏病学专业学术会议之一,本届论坛吸引了来自全国的两千余名参会代表以及河南当地的约一千名基层医生,论坛以其鲜明的学术主题和特色,为与会者提供了一场学术盛宴,受到参会者的一致好评.     

第15届全国介入心脏病学论坛通知

由中国医师协会、中国医师协会心血管内科医师分会、中华医学会心血管病学分会、中国医学基金会主办,中国介入心脏病学杂志、北京力生心血管健康基金会、北京麦迪卫康广告有限公司承办,广西医科大学附属第一医院协办的第15届全国介入心脏病学论坛将于2012年3月1—4日在广西南宁举行。     

Spanish cardiac catheterization and coronary intervention registry. 20th official report of the spanish society of cardiology working group on cardiac catheterization and interventional cardiology (1990-2010)

Introduction and objectives

The Working Group on Cardiac Catheterization and Interventional Cardiology presents on a yearly basis a report on the data collected for the national registry. This information displays how procedures are distributed throughout Spain and makes comparisons with other countries feasible.

Methods

Institutions render their data voluntarily (online) and they are analyzed by the Working Group's steering committee.

Results

Data was sent by 113 hospitals (71 public and 41 private) that treat mainly adults, reporting 135 486 diagnostic procedures, 119 118 of them coronary angiograms, slightly less than the year before, and with a rate of 2945 coronary angiograms per million inhabitants. Percutaneous coronary interventions increased a bit, to 64 331 procedures and a rate of 1398 interventions per million. Of 100 371 stents implanted, 61.3% were drug-eluting stents. In the acute phase of myocardial infarction, 14 248 coronary interventions were carried out, 6% more than in 2009 and 22% of the total number of coronary interventions. The most frequent intervention for adult congenital heart disease was closure of an atrial septal defect (295 procedures). Percutaneous mitral valvuloplasty continues to decrease (326 procedures) and percutaneous aortic valve implantations are growing rapidly, with 655 units implanted in 2010.

Conclusions

The greatest increase in activity has occurred in the field of myocardial infarction and percutaneous aortic valve implantation. The other procedures, both diagnostic and therapeutic, remain stable.Full English text available from:www.revespcardiol.org     

Towards evidence-based percutaneous coronary intervention: The Rene Laennec lecture in clinical cardiology

Percutaneous coronary intervention (PCI) has matured from a pioneering adventure focused on feasibility to a major sub-specialty delivering real clinical results to patients. Despite delivering reductions in mortality and morbidity in the field of acute coronary syndrome and overcoming in-stent restenosis, several challenges still remain. Firstly, we need to adhere to practices supported by established trials: data relating to PCI in stable angina and late reopening of occluded infarct-related vessels suggest that this is not always the case. Secondly, we must develop new trials asking clinically relevant questions in 'real-world' populations that are focused on patient-based outcomes. Finally, given the current global financial crisis, it is now more important than ever that we demonstrate cost-effectiveness in our clinical practice. In these turbulent times, we discuss the challenges ahead for PCI in its journey towards evidence-based practice.     

Perspective on invasive cardiology: The 24th Louis F. Bishop lecture

The fast growing and field of invasive cardiology offers a host of oppurtunities and challenges for the clinician. Scientific and technical advances ranging from molecular biology to microtechnology are changing how physicians make decisions concerning treatment of coronary artery disease, myocardial infarction, unstable angina and electrephysiologic dysfunction. The economic impact and ethical implications presented by these developments contribute to the difficulty of achieving optimal therapeutic solutions for individual patients.